Veeva Systems Inc. NYQ · VEEV
Price alert —
Sign in to get a one-time email the moment VEEV crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · VEEV
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-04-30 | $0.9B | $0.3B | $0.3B | $1.1B | 29.6% | 30.9% |
| 2026-01-31 | $0.8B | $0.2B | $0.2B | $0.1B | 29.2% | 29.4% |
| 2025-10-31 | $0.8B | $0.2B | $0.2B | $0.2B | 29.1% | 29.7% |
| 2025-07-31 | $0.8B | $0.2B | $0.2B | $0.2B | 25.4% | 24.8% |
| 2025-04-30 | $0.8B | $0.2B | $0.2B | $0.9B | 30.1% | 30.8% |
| 2024-10-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare VEEV vs peers
Line VEEV up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with VEEV
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-06-03 | 2.24 | 2.14 | +4.9% | -0.1% |
| 2026-03-04 | 2.06 | 1.94 | +6.5% | +4.0% |
| 2025-11-20 | 2.04 | 1.95 | +4.5% | -9.8% |
| 2025-08-27 | 1.99 | 1.90 | +4.8% | -7.2% |
| 2025-05-28 | 1.97 | 1.74 | +13.0% | +19.0% |
| 2025-03-05 | 1.74 | 1.58 | +10.1% | +7.4% |
| 2024-12-05 | 1.75 | 1.58 | +10.7% | +8.1% |
| 2024-08-28 | 1.62 | 1.53 | +5.6% | +8.9% |
| 2024-05-30 | 1.50 | 1.42 | +5.3% | -10.3% |
| 2024-02-29 | 1.38 | 1.30 | +6.2% | -1.6% |
| 2023-12-06 | 1.34 | 1.29 | +3.7% | -3.0% |
| 2023-08-30 | 1.21 | 1.13 | +7.3% | +8.4% |
| 2023-05-31 | 0.91 | 0.80 | +13.6% | +19.7% |
| 2023-03-01 | 1.15 | 1.04 | +10.6% | +4.5% |
| 2022-12-01 | 1.13 | 1.07 | +5.3% | -8.6% |
| 2022-08-31 | 1.03 | 1.01 | +1.9% | -14.0% |
| 2022-06-01 | 0.99 | 0.92 | +7.3% | +14.7% |
| 2022-03-02 | 0.90 | 0.88 | +2.0% | -16.2% |
| 2021-12-01 | 0.97 | 0.88 | +10.6% | -3.6% |
| 2021-09-01 | 0.94 | 0.86 | +9.0% | -5.4% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| VEEV ★ | $32B | 34.6 | 19.5 | 9.6 | 23.9 | 4.4 | 75.0% | 16.3% | 14.6% | 3.97% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 20.2 | 4.0 | 18.8% | 2.0% | 0.7% | 4.57% |
| JNJ | $609B | 29.4 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 35.9 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.3 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 33.18%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 11,558,875 | 7.12% |
| Vanguard Portfolio Management LLC | 7,376,031 | 4.54% |
| Vanguard Capital Management LLC | 6,670,318 | 4.11% |
| Alliancebernstein L.P. | 6,271,098 | 3.86% |
| Linonia Partnership LP | 4,924,626 | 3.03% |
| Principal Financial Group, Inc. | 4,141,545 | 2.55% |
| State Street Corporation | 3,608,655 | 2.22% |
| T. Rowe Price Investment Management, | 3,405,594 | 2.10% |
| Geode Capital Management, LLC | 3,312,734 | 2.04% |
| FMR, LLC | 2,613,526 | 1.61% |
Insider activity · 90d
1 buys / 0 sells · ratio 1.0 · Finnhub
- Zuppas Eleni Nitsa M 6,541
- Zuppas Eleni Nitsa M 33,418
- Van Wagener Brian M 4,906
- Van Wagener Brian F 9,325 @ $184.22
- Van Wagener Brian M 10,018
- Schwenger Thomas D. M 8,721
- Schwenger Thomas D. F 25,449 @ $184.22
- Schwenger Thomas D. M 26,566
- Kondath Vipin M 502
- Kondath Vipin F 2,783 @ $184.22
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-06 | FORM 4 | view · |
| 4 | 2026-07-06 | FORM 4 | view · |
| 4 | 2026-07-06 | FORM 4 | view · |
| 4 | 2026-07-06 | FORM 4 | view · |
| 4 | 2026-07-06 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 4 | 2026-06-22 | FORM 4 | view · |
| 8-K | 2026-06-18 | 8-K | view · |
| 10-Q | 2026-06-05 | 10-Q | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 8-K | 2026-06-03 | 8-K | view · |
| 4 | 2026-05-04 | FORM 4 | view · |
| DEF 14A | 2026-05-04 | DEF 14A | view · |
| 8-K | 2026-04-20 | 8-K | view · |
| 4 | 2026-04-14 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-09 | FORM 4 | view · |
| 4 | 2026-04-03 | FORM 4 | view · |
| 4 | 2026-04-03 | FORM 4 | view · |
| 4 | 2026-04-03 | FORM 4 | view · |
| 4 | 2026-04-03 | FORM 4 | view · |
| 4 | 2026-04-03 | FORM 4 | view · |
| 10-K | 2026-03-20 | 10-K | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 8-K | 2026-03-04 | 8-K | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-01-15 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
| 8-K | 2026-01-05 | 8-K | view · |
| 4 | 2025-12-11 | FORM 4 | view · |
| 8-K | 2025-12-11 | 8-K | view · |
| 4 | 2025-12-03 | FORM 4 | view · |
| 4 | 2025-12-02 | FORM 4 | view · |
About VEEV
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which i…
Options picks · VEEV
ITM + OTM ideas from the latest scanLoading…
Congress trades · VEEV
STOCK Act disclosuresLoading…
SEC filings & insiders · VEEV
EDGAR · liveLoading…
Holders · VEEV
Institutions & insider activityLoading…